Global Gastroenterology Ambulatory Surgery Center Market Size

Gastroenterology Ambulatory Surgery Center Market Analysis

The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).

The COVID-19 pandemic seemed to negatively impact the market's growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff-also, prioritizing only the emergency cases negatively impacted the market's growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market's growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.

The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market's growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market's growth.

Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market's growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data published in June 2021, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. Other driving factors include the rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies. For instance, as of August 2022, there were around 35967 ongoing clinical trials related to gastrointestinal diseases across different phases of development, as per the National Clinical Trial (NCT) registry. The positive outcomes from these studies can create new opportunities for an increase in gastroenterology ambulatory surgery center over the forecast period.

Thus, due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.